chrisvoncsefalvay/vaers-outcomes huggingface dataset:
feeling tired; has some fever/has a slight fever of 37.8 C; Headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Lot number: FH8028, Expiration Date: 28Feb2022) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose number: 1), for Covid-19 immunization; Bnt162b2 (Dose number: 2), for Covid-19 immunization. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "feeling tired"; PYREXIA (non-serious), outcome "unknown", described as "has some fever/has a slight fever of 37.8 C"; HEADACHE (non-serious), outcome "unknown", described as "Headache". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: The caller is calling about the Pfizer covid 19 vaccine. The caller and her husband took the booster shot of the Pfizer covid 19 vaccine. When they came home, the expiration date on the caller's husband's said 28Feb2022. The vaccination cards have a sticker on it with the product information on it, it is not handwritten. Both the caller and her husband's lot was FH8028. The patient is feeling tired and has some fever. The patient has a headache, is tired and has a slight fever of 37.8 C. The patient has been staying in bed. The patient has a headache and is very tired.  Follow-up attempts are completed. No further information is expected.
Fever, chills, muscle aches, bronchitis type symptoms 24 hours after vaccine administered. Symptoms started resolving 4 days later.
Pt to clinic and left deltoid with erythema and slight swelling and warm to touch. Pt states "it doesn't hurt" advised mom to see PMD.
adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (adverse reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (adverse reaction). At the time of the report, ADVERSE REACTION (adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information were not provided.
Parent reported 99.6 temp the morning after receiving immunizations at kindergarten physical. That evening temp went up to 102. Had 1 minute episode of jerking of arms and legs and unresponsiveness. Child taken to ER for evaluation. No subsequent SX. No treatment or labs done. Will schedule EEG. Diagnosis per ED: Febrile Seizure.
warm flushes, aches generalized, malaise, nausea, 1 day p/receiving flu vax;
Intolerable pain (R) arm since 9PM of day of vaccine. Unable to move arm for 3-4days. Physical Therapy stated 8 days after injection. Pain continues today.
Dizziness while sitting in observation room. Hx of Anxiety. Symptoms improved after eating snack and laying down.  Left ambulatory in steady gait with husband
SX: lightheaded, feeling faint, losing BP 110/70 color and clammy. TX: Food (crackers with chesses), water, stayed an additional 15 minutes. Patient felt better after 23 minutes and left in good spirits.
discoloration (bruise) / were the vaccine was injected; soreness in the area where the vaccine; developed black and blue discoloration (bruise) in the area where the vaccine was applied.; This case was reported by a pharmacist via call center representative and described the occurrence of injection site bruising in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th November 2021, the patient received the 1st dose of Shingrix. In November 2021, less than a week after receiving Shingrix, the patient experienced injection site bruising, injection site pain and injection site discoloration. On an unknown date, the outcome of the injection site bruising, injection site pain and injection site discoloration were unknown.   It was unknown if the reporter considered the injection site bruising, injection site pain and injection site discoloration to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the first dose and developed black and blue discoloration (bruise) and also developed soreness in the area where the vaccine was applied. The reporter agreed to be contacted for follow up.  The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021235306:same reporter
Patient was on site for his second dose of the Moderna vaccine. Upon administration, the nurse noticed that the needle was not properly attached to the syringe. The vaccine leaked out of the syringe. The patient did not receive much of the dose, if any. Doctor was called and informed of the event. She instructed the nurse to administer a full dose into the patient's other arm (right arm). The patient was informed of what had happened and given the option to proceed. The patient expressed understanding and gave consent. The dose was administered, and the patient waited the standard 15 minutes for monitoring.
Information has been received from a registered nurse concerning a 43 month old male who in 1998 was vaccinated with varicella vaccine. The registered nurse reported that the pt presented to the doctor's office on approx. 05/14/2001 with chicken pox. The nurse reported that the pt had vesicular, itchy rash mainly on the trunk of the body but no fever. The registered nurse also reportd on the pt's three siblings who experienced an event following vaccination with varicella vaccine live. Additional info has been requeted.
Appendicitis; This literature-non-study case was reported in a literature article and describes the occurrence of APPENDICITIS (Appendicitis) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.   LITERATURE REFERENCE:  No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced APPENDICITIS (Appendicitis) (seriousness criterion medically significant). At the time of the report, APPENDICITIS (Appendicitis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant and treatment medications were not reported.  This study described simultaneous vaccination (SV) with primary series COVID-19 vaccines and assess 23 pre-specified health outcomes following SV among persons aged =5 years.  This study utilized COVID-19 vaccine surveillance data from December 11, 2020-May 21, 2022. Analyses assessed frequency.   Rate ratios (RRs) were estimated by Poisson regression when the number of outcomes was =5 across both doses, comparing outcome rates between COVID-19 vaccinees receiving and COVID-19 vaccinees receiving no in the 1-21 days following COVID-19 vaccine dose 1 and 1-42 days following dose 2 by SV type received.  The most frequent simultaneous vaccines were influenza, HPV, Tdap, and meningococcal. Outcomes following with COVID-19 vaccines were rare (total of 56 outcomes observed after dose 1 and dose 2). Overall rate of outcomes among COVID-19 vaccinees who received SV was not statistically significantly different than the rate among those who did not receive.  The most frequent simultaneous vaccines were influenza, HPV, Tdap, and meningococcal. Outcomes following SV with COVID-19 vaccines were rare (total of 56 outcomes observed after dose 1 and dose 2). Overall rate of outcomes among COVID-19 vaccines who received SV was not statistically significantly different than the rate among those who did not receive.  This is a literature non-study case concerning a patient of unknown age and gender with no reported medical history, who experienced the serious (due to medically significant) unexpected, AESI appendicitis. The event occurred after a dose of mRNA-1273 vaccine. (no date provided so latency could not be calculated) No treatment nor diagnostic test provided. The outcome of the event was reported as unknown. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2023-731248 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-731248:Seizure patient
My head hair and some body hair first fell out when I was age 9. A couple of times it grew back, but finally fell out completely when I was age 25. However, since then, I've always had hair on my arms, underarms, legs, chest, and genitals, although there were patchy spots in places without hair. In addition, I've had to shave my face daily, although the growth was much lighter than most men, and I also had constant peach fuzz on my head that required shaving every week to week and a half. Now, after getting the two vaccines at age 68, 98-99% of all my hair is suddenly gone over my entire body. I still have brown colored nose hair and eyelashes although they appear thinner and less dense. My chin hair is very patchy and white. I haven't shaved my head in probably 3 months and there is no sign of any peach fuzz. I noticed that the hair was primarily gone before I got the booster on 11/27/2021. What is interesting is that I received a vaccine at age 8 (1960) when in 3rd grade. a few months later, I started losing my hair and by the middle of 4th grade, I was completely bald at age 9.
About four months after the fourth dose of my COVID-19 vaccine I felt unwell and then achy. I think I had a fever of 101.4. It was a general malaise like I had the flu. I was lethargic and sleepy, and I felt bad. My nurse gave me information on a medication, but I didn't take it. My symptoms lasted about four days. I was still a little tired after that time which lasted one to two weeks after.
Patient received expired dose of the Moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of the Moderna vaccine) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of the Moderna vaccine). On 27-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Patient received expired dose of the Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported.  No treatment reported.   This case was linked to MOD-2021-338604 (Patient Link).
A non-serious spontaneous report of two children administered expired FLUMIST was received from a health professional concerning an eight-year-old patient. Neither the patient's past medical history nor any concomitant medications were reported. The product expired on 08-Dec-2010. The patient received the expired FLUMIST on 14-Dec-2010. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved. Additional information received on 01-Mar-2011: no late occurring adverse events.
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 74-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05May2022 at 14:30 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 73 years, in left arm for covid-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunization. The patient had no relevant medical history. Concomitant medication(s) included: SYNTHROID; PRAVACHOL; PRILOSEC [OMEPRAZOLE]; ASA; METOPROLOL. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 10Oct2022 at 16:00, outcome "not recovered" and all described as "COVID 19". Patient had no known allergies. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Treatment of COVID-19; (unspecified date) Negative; (unspecified date) Negative; (unspecified date) Negative; (10Oct2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical Information: The Paxlovid Treatment received on 02Oct2022 and stopped on 06Oct2022. The patient tested negative for 3 days following treatment then rebounded with testing positive and return of symptoms.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product bnt162b2 to the reported drug ineffective / COVID-19 cannot be ruled out
Hives, extremely itchy first night, lump under injection site, warm to touch, swelling above and below eyes
69-year-old male who is demented presents the emergency department by EMS from local nursing home.  He sustained a fall with a minor injury to the top of his head.  No blood thinners.  He also has a history of A. fib and is little hypotensive.  Wife wanted him checked out.  He does not complain of anything.  He does have a very minor abrasion to the top of his head.  I noted he was admitted back in June for acute renal failure.
shortness of breathe; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breathe) in a male patient of an unknown age who received mRNA-1273 (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Apr-2021, the patient received second dose of mRNA-1273 (unknown route) dosage was changed to 2.  On an unknown date, the patient received first dose of mRNA-1273 (Intramuscular) 1.   On 28-Apr-2021, the patient experienced DYSPNOEA (shortness of breathe). At the time of the report, DYSPNOEA (shortness of breathe) had resolved.     Concomitant medication use was unknown.  Treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: No specific follow-up information recorded.
Patinet was given Tdap, Hep A and Menactra and they just got these same ones a year ago; patient did not supply us with correct information prior to shots.
Patient was administered the GARDASIL 9 first dose in series vaccine at 7:39 PM in the left arm at the pharmacy after counseling. At 7:40 PM patient passed out, eyes rolled back into the head and lost consciousness. 911 was called and patient quickly regained consciousness and pharmacist walked through EMS guidance to triage patient until EMS arrived. They were on site within 5 mins. they took vitals and checked patient. Pharmacist continued to observe patient under direct supervision until his parents arrived on the scene.
Red, warm, mildly tender at injection site on 12/17/99. On 12/18/99, seen by Dr. who prescribed continuation of Omnicef that patient was taking for ear infection. No other tx given.
Case number PHEH2014US003794 is an initial spontaneous report received from a pharmacist on 21 Feb 2014 with follow-up received on 24 Mar 2014. This report refers to a 64-year-old female patient. The patient's medical history and concomitant medications were not reported. It was reported that this patient over 55-years of age was vaccinated with a dose of MENVEO (batch number: A11052) intramuscularly into left deltoid at a dose of 0.5 ml on 21 Sep 2013 at 12:15. No adverse event was reported following the maladministration.
Appendicitis!  Needed emergency surgery.  3/18 Received  Moderna Vaccine 3:40pm health center   3/19 Slight pain in stomach in AM, by 12:30pm vomitted twice and severe stomach pain.  3/19: 2:30pm checked in at Hospital Throwing up constantly and severe stomach/abdominal pain.  Cat scan showed appendicitis and needed emergency surgery to remove appendix.
Severe headache Weakness / fatigue Swollen/bruised arm (it was as big as the size of a tennis ball; I have a picture of it on my cell phone) Aching allover; specially arm, shoulders high fever up to 103.4 (for 3 days) lost of appetite (3-4 Days) Took Tylenol every 4-6 hrs; place iced were shot was given, drink lots of fluid, and warm bath to help with the fever. Contacted the on call service doctor on 10/23/10, told them about my symptom, and I was told that it did not sounded like a reaction from the shot. That I can either go the next day to an urgent care or see them on Monday.
Swelling of tongue and throat, flushing, hives, shortness of breath, cough within 45 min of injection
Painful warm erythema swollen circle, increasing in size, about 4 cm wide.
Patient received a Covid Booster on 1/11/22 at a healthcare facility . The next morning  he woke up with a large swollen and tender lymph node under the arm where he got the shot.
TOTAL BODY SEVERE PAIN OF ALL JOINTS AND MUSCLES (FROM HEAD TO TOE, PLUS PAIN BEHIND BOTH EYES
Fever, headache, nausea, muscle pain, fatigue, pain at injection site, arm soreness
Fast heartbeat approximately 12 hours after receiving the vaccine while in bed sleeping.  Lasted for about 3 hours.  Did not seek medical attention - maybe should have.  Got up about 6 am.  Had breakfast and symptoms went away.  No - I was not starving myself that day or any other day.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The pertinent medical history and concomitant medication was not reported. On 19-JUN-2015, the patient was vaccinated with unspecified number of improperly stored doses of MMR II (lot: K004949 and Expiry: 04-APR-2016) (route unspecified). No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Narrative:  93 year old patient was found to have covid19 after full vaccination (Pfizer 2/12, 3/5/2021). Pt tested positive on 7/12/2021 while he was inpatient. Pt was admitted for left hip pain (left femoral hip fracture) on 7/11/2021. On 7/13, he under went left partial hip arthroplasty from the fracture and developed hypotension and AMS, he was also found to have hbg of 7.6 (drop from 7.6). Pt required 3 units of pRBCs, his course was also complicated with UTI and type 2 NSTEMI from hemorrhagic shock. Hospice care discussed with family. Pt was found to be unresponsive on 7/14/2021. Medical cause of death listed as: *Hemorrhagic shock and acute coronary syndrome or pulmonary emboli
Slight soreness for 1 day then ache went away.  On Sunday, 12/26/2021, Injection site began aching again to the point it became noticeable around noon. Has continued to grow in ache for past 2 days. Is beginning to become a sharp pain when I raise arm.
Have had severe muscle spasms for the last 29 days, headaches, chills, fever, numbness on my feet, and a fast heart rate. I have been putting pain patches on affected areas as well as cold and hot compresses. I am also getting treatment from a Neurophat doctor and a kiropractor. I drink lots of teas and take Tylenol When ever the pain is very severe. I am resting as much as I can and exercise as much as I can.  I have reduced my food intake to only vegetables, protein, and drinking hydrating coconut water and lots of plain water.
Pt received booster dose of Pfizer (gray top) adult vaccine at 1539. At 1554, mother approached nurse and stated pt. Had blurred vision/ lightheadedness. Nurse gave patient a small can of apple juice to drink immediately and stood to observe the patient longer. Pt stated he hadn't eaten lunch since 1130 so the RN gave the patient a bag of graham crackers but the patient refused to eat right away because he didn't feel comfortable taking off his mask in a crowd. By 1604, after drinking the entire can of juice, patient still stated he had a headache and he cant tell if his vision is getting worse or not. Mom requested we get a hold of his pediatrician (in the building) and the RN stated that she will call an MD to check out the patient first. MD called at 1604 and they arrived 1605. First set of vitals were Temp: 99.2 HR:112 Sat 99 and BP 181/78 but patient was feeling anxious by the amount of people that showed up. His follow up vitals were 99.2 HR 102 BP 137/76 sat 100. Dr. (Pediatrician) spoke to mom and determined he was stable enough to go back to his Pediatrician Dr. and he left via wheelchair at 1612
Information has been received from a physician concerning an "over 65 years old" patient who was vaccinated with PNEUMOVAX 23 (lot number not available). Subsequently the patient "experienced swelling at the injection site". At the time of the report, the patient recovered from swelling at the injection site. Follow-up information has been received from a physician concerning a patient allergic to sulfonamide and codeine who on 15-JAN-2009 was vaccinated with a dose of PNEUMOVAX 23 into the left deltoid. Subsequently the patient developed cellulitis of injection site and experienced sore of injection site. The patient required an emergency room visit. Then the patient was hospitalized. At the time of the report, the patient recovered. This is one of several reports received from the same source. Additional information is not expected.
Developed redness and swelling at site of injection. Mild cellulitis. Treated with Augmentin and steroids. Pt has yet to follow-up.
This spontaneous report was received from a certified medical assistant referring to a currently 13 months old patient of unknown gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On an unknown date, the patient was vaccinated with an improperly stored dose of VAQTA, lot number N017094 and expiration date of 31-AUG-2018 for prophylaxis (dose and route of administration were not provided). The vaccine was exposed to a temperature excursion of 47.1°F with a time frame of 30 minutes. There was no previous temperature excursion. A "data logger" was involved. No adverse effects were reported. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1710USA006357: US-009507513-1710USA006358: US-009507513-1710USA006359: US-009507513-1710USA006360: US-009507513-1710USA006361: US-009507513-1710USA006362: US-009507513-1710USA006373: US-009507513-1710USA006364: US-009507513-1710USA006365: US-009507513-1710USA006366: US-009507513-1710USA006367: US-009507513-1710USA006368: US-009507513-1710USA006369: US-009507513-1710USA006370: US-009507513-1710USA006371: US-009507513-1710USA006372: US-009507513-1710USA006356: US-009507513-1709USA011980: US-009507513-1710USA006363:
Patient states having lightheadedness and some dizziness that is worse upon getting up for sitting/laying.
Information has been received from a registered pharmacist concerning a male patient who "the week of 09-JUN-2010" was vaccinated with ZOSTAVAX (Merck). The registered pharmacist reported that the patient developed an unspecified rash. The rash developed within 5 days of vaccination. The outcome of the patient was not reported. The patient sought medical attention and spoke to the pharmacist. Additional information has been requested.